ACTRN12608000096358终止3 期
Efficacy and safety of adjuntice zonisamide in primary generalised tonic clonic seizures
Eisia G.C.D., Eisai Ltd.0 个研究点目标入组 154 人开始时间: 2008年2月20日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 发起方
- 入组人数
- 154
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 6 Years 至 60 Years（—）
- 性别
- All
入选标准
- •primary generalized tonic clonic seizures
排除标准
- •any other type of epilepsy
研究者
相似试验
进行中（未招募）
2 期
Study on efficacy and safety of zonisamide in at-risk subjects of Lewy body diseaseJPRN-jRCTs041190126Katsuno Masahisa30
已完成
4 期
A Clinical Trial to evaluate the safety and efficacy of zonisamide an antiepileptic drug in treatment patients with seizures (Fits). This is a postmarketing study to further confirm the safety and efficacy in large number of patients in the approved types of seizures.CTRI/2010/091/002925Eisai Pharmaceuticals India Private Limited.1st Floor, B-Wing, Marwah Centre, Krishanlal Marwah Marg, Andheri East, Mumbai - 400072655
已完成
不适用
on-inferiority study of zonisamide versus levodopa preparations in DLB parkinsonismParkinsonism with Dementia with Lewy bodiesJPRN-jRCTs051200054Ikeda Manabu130
已完成
不适用
Effect of Zonisamide and Pregabalin in control of interactable epilepsy in childreInteractable epilepsy.Episodic and paroxysmal disordersIRCT2012091210508N4Shahid Beheshti University of Medical Science96
已完成
不适用
Safety and efficacy of extended pyrazinamide (PZA) administration for prolonged smear positive pulmonary tuberculosispulmonary tuberculosisJPRN-UMIN000012243ational Center for Global Health and Medicine40